Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Insights - The company achieved a revenue of 7.49 billion yuan in 2025, a year-on-year increase of 1.2%, while the net profit attributable to shareholders was 178 million yuan, a decrease of 24.6% year-on-year [4][10] - The company's domestic milk powder business faced pressure due to the internal code adjustment, while overseas goat milk powder and cheese businesses showed significant growth [5][8] - The company is expected to recover domestic revenue growth in 2026, driven by the completion of internal code adjustments and a low base in 2025, while overseas markets are projected to maintain high double-digit growth [8] Summary by Sections Revenue and Profit Performance - In 2025, the company reported revenues of 7.49 billion yuan, with a net profit of 178 million yuan, reflecting a decline in profitability due to internal adjustments [4][10] - The second half of 2025 saw revenues of 3.6 billion yuan, a decrease of 3.2% year-on-year, with a net loss of 3 million yuan [4] Product Performance - Revenue breakdown for 2025 includes: cow milk powder (1.767 billion yuan, -16.1%), domestic goat milk powder (2.579 billion yuan, -15.5%), overseas goat milk powder (974 million yuan, +50.7%), nutrition products (320 million yuan, +5.2%), and cheese (1.006 billion yuan, +448.1%) [5] - The overseas goat milk powder business emerged as a key growth driver, with significant revenue increases in the Middle East (45.7% of overseas revenue, +65.5% year-on-year) and North America (39.5% growth) [5][6] Cost and Margin Analysis - The overall gross margin for 2025 was 38.6%, down 3.3 percentage points year-on-year, primarily due to lower margins from the newly consolidated cheese business and rising raw material costs [7] - The company expects an improvement in gross margin in 2026, driven by the completion of internal code systems and an increase in high-margin overseas business [7] Future Outlook - The completion of internal code adjustments is anticipated to stabilize domestic revenue, with expectations for single-digit growth in 2026 [8] - The company is well-positioned for long-term growth, supported by strong brand and channel barriers, particularly in the goat milk powder segment [8]

Group 1: 康方生物 - Company maintains a "Buy" rating for 康方生物 with a target price of HKD 185.80, expecting product sales revenue to reach HKD 3 billion in 2025, a 52% year-on-year increase, driven by Cadonilimab and Ivonescimab entering the national medical insurance directory [1] - Ivonescimab has shown significant improvement in progression-free survival in head-to-head Phase III clinical trials, with key global data readout imminent [1] - The FDA review target date for EGFR-TKI resistant NSCLC indication is set for November 2026, potentially marking the company's first FDA-approved product [1] Group 2: 中国铁塔 - Company maintains a "Hold" rating for 中国铁塔 with a target price of HKD 12.10, projecting a 2.7% revenue growth to HKD 100.4 billion in 2025, and an 8.4% net profit increase to HKD 11.6 billion [1] - Revenue from the communication tower business is expected to decline by 0.3% year-on-year due to continued capital expenditure reductions from the three major operators [1] - DAS and "two wings" businesses are anticipated to maintain double-digit growth, contributing to revenue diversification [1] Group 3: 信达生物 - Company maintains a "Buy" rating for 信达生物 with a target price of HKD 113.86, forecasting a first-time annual profit of HKD 834 million in 2025, with product sales revenue reaching HKD 11.9 billion, a 45% year-on-year increase [2] - Key growth drivers include newly launched products Mazdutide, PCSK9 monoclonal antibody, and IGF-1R antibody [2] - Collaboration with Takeda to advance IBI363 into global Phase III clinical trials, with multiple assets entering or nearing global multi-center Phase III [2] Group 4: TCL电子 - Company maintains a "Buy" rating for TCL电子, expecting 2025 revenue of HKD 114.6 billion, a 15.4% year-on-year increase, and a net profit of HKD 2.5 billion, a 41.8% increase [3] - Growth is primarily driven by a 15.7% increase in overseas television revenue, a doubling of Mini LED shipments, and a 63.6% surge in photovoltaic business revenue [3] - Joint venture with Sony is imminent, expected to enhance high-end channel access and improve profitability [3] Group 5: 小马智行-W - Company maintains a "Buy" rating for 小马智行-W with a target price of HKD 195, projecting a 129% year-on-year increase in Robotaxi revenue in 2025 [4] - Achieved positive unit economics in Guangzhou and Shenzhen, with peak daily revenue per vehicle reaching HKD 394 [4] - The BOM cost of the seventh-generation model has decreased by 20% compared to the previous generation, with plans to expand the fleet to 3,000 vehicles [4] Group 6: 优然牧业 - Company maintains a "Buy" rating for 优然牧业, forecasting a 13.2% increase in raw milk sales volume to 4.15 million tons in 2025, with per cow production rising to 12.8 tons/year [5] - Feed cost per kilogram of milk is expected to decrease by 10.5%, with cash EBITDA reaching HKD 5.59 billion, a 4.9% year-on-year growth [5] - Anticipation of a dual-cycle resonance point for milk and meat prices in 2026 due to ongoing industry capacity reduction and rising beef prices [5] Group 7: 移卡 - Company maintains an "Outperform" rating for 移卡 with a target price of HKD 8.90, projecting a domestic payment rate increase to 12.3 bps and a 3.2-fold increase in overseas GPV to HKD 4.7 billion in 2025 [6] - This growth is expected to drive an 8% increase in acquiring revenue [6] - Integration of AI throughout the operational process has led to a 13% reduction in sales and management expenses, with core EBITDA growing by 53% to HKD 350 million [6] Group 8: 中国民航信息网络 - Company maintains a "Buy" rating for 中国民航信息网络 with a target price of HKD 15.70, expecting a 4.9% growth in aviation information technology processing volume and an 18.8% increase in revenue from smart travel products and services in 2025 [7] - Revenue from airport digital services is projected to decline by 20.8% due to construction schedule impacts, but significant cost reductions in depreciation and amortization are expected to enhance operating profit margins by 3.6 percentage points to 30.9% [7] Group 9: 碧桂园服务 - Company maintains an "Accumulate" rating for 碧桂园服务 with a target price of HKD 7.24, forecasting a 10% revenue growth to HKD 48.35 billion in 2025, while core net profit is expected to decline by 17% to HKD 2.52 billion [8] - The decline is attributed to pressure on community value-added services and increased impairment of receivables [8] - Annualized revenue growth from market expansion is projected to reach 87% to HKD 2.03 billion, with a significant increase in shareholder returns, raising the dividend payout ratio to 60% [8] Group 10: 赤子城科技 - Company maintains an "Accumulate" rating for 赤子城科技, projecting a 32.9% year-on-year increase in social business revenue to HKD 6.14 billion in 2025 [9] - Revenue from SUGO and TopTop is expected to grow by over 80% and 70%, respectively, with rapid expansion in emerging markets such as Latin America and Japan [9] - Innovative business revenue is projected to grow by 59.3%, driven by the launch of AI self-developed models Boomiix and creative community Aippy, forming a second growth curve through "diversified matrix + global expansion" [9]

Summary of Key Points from Conference Call Records Industry Overview - The white liquor industry is currently in a bottoming phase, with 2026 designated as a year for price stabilization, shifting focus towards C-end operations and repurchase cultivation [1][2][3] - The liquor market is experiencing a transition from competition for traffic to user operation and repurchase cultivation, with leading companies focusing on precise connections at main venues [2][3] Key Insights on White Liquor - Moutai's price has stabilized at 1,600 RMB, showing double-digit growth during the Spring Festival, while Wuliangye plans to maintain prices above 800 RMB in Q2 [1][2] - The white liquor sector is expected to see improved forecasts after financial report pressures are released by the end of April [1] - Inventory reduction and channel profit changes will be key focuses in the first half of 2026, with companies that adjust first likely to see marginal improvements in the second half [2][3] Performance of Major Brands - **Moutai**: Expected annual growth rate of 7.5% during the 14th Five-Year Plan, with a controlled sales volume providing a solid price floor [2] - **Wuliangye**: Achieved double-digit growth during the 2026 Spring Festival compared to 2024, with plans to reduce volume and tighten channel policies to push prices back up [4] - **Luzhou Laojiao**: Adopted a price maintenance strategy, with a decline in high-end product sales but stable low-end product performance [4] - **Fenjiu**: Experienced better-than-expected sales during the Spring Festival, with a focus on mid-range products showing resilience [5] Market Dynamics and Investment Strategies - The overall market sentiment among distributors is calm, with expectations of weak sales being accepted [3] - The investment strategy for the white liquor sector suggests continued pressure in March and April, with potential for recovery post-financial report disclosures [2][9] - Key recommended stocks include Moutai and Wuliangye, with Fenjiu also being highlighted for its potential rebound [10] Other Beverage and Food Industry Insights - The dairy sector is seeing a recovery in demand, with moderate price increases benefiting leading companies like Yili and Mengniu [1][13] - The restaurant supply chain is benefiting from improved demand, with companies like Haitian and Yihai showing double-digit growth in early 2026 [1][12] - The beer sector remains stable, with Yanjing Beer showing growth driven by its U8 product [10][11] Conclusion - The white liquor industry is on the verge of recovery, with key players like Moutai and Wuliangye positioned to benefit from price stabilization and improved market conditions in 2026 [9][10] - The overall investment landscape in the beverage and food sectors is promising, with specific focus on companies that can adapt to changing consumer demands and market conditions [12][20]

Summary of Key Points from Conference Call Records Industry Overview - The liquor industry is currently in a bottom recovery phase, with expectations that performance in 2026 will not be worse than in 2025, and a potential exit from the industry cycle is anticipated around 2027-2028 [1][3] - The consumption structure is shifting towards the mass price range of 100-300 RMB, with Moutai and Wuliangye adopting a price-for-volume strategy, while Guojiao 1573 maintains a controlled supply to support prices, resulting in a double-digit decline in sales [1][3] Core Trends and Market Consensus - The overall atmosphere at the 2026 Spring Sugar and Wine Fair was rational and contractionary, with major brands like Moutai and Wuliangye significantly reducing their exhibition investments, indicating a focus on cost-effectiveness [2] - The market confidence is still in the recovery process, with distributors adopting a cautious approach regarding inventory and payments [2] - The C-end (consumer-end) trend is becoming more pronounced, with companies accelerating their strategies to embrace direct consumer engagement [4][7] New Channels and Growth Opportunities - Instant retail is emerging as a new growth point, with the market size expected to exceed 50 billion RMB by 2025, and a compound annual growth rate of approximately 50% projected for the coming years [1][5] - The penetration rate of instant retail in the overall liquor market is currently only 2-3%, indicating significant growth potential [5] Company-Specific Insights Moutai - Moutai's sales policy emphasizes the assessment of distributors, with expectations for stable pricing around 1,499 RMB for its flagship product [7] - The company is expected to achieve positive growth in Q1 2026, supported by a robust distributor network and a focus on quality sales [7] Wuliangye - Wuliangye has optimized its distribution structure by significantly reducing shipments during the off-season to maintain price stability above 800 RMB [8][9] - The company aims to expand its quality terminal network and enhance sales capabilities [9] Luzhou Laojiao - Luzhou Laojiao is focusing on youth-oriented and low-alcohol products, with a strategic emphasis on digital applications in 2026 [10] - The company has introduced new products to cater to the low-alcohol market, which is expected to grow significantly [10] Regional Brands - Shanxi Fenjiu is managing inventory and pricing strategies amid a contraction phase, while Anhui's Gujing Gongjiu and Jiangsu's Yanghe are experiencing varied performance based on market conditions [11] Investment Recommendations - The liquor sector is expected to face pressure in Q1 2026, but a positive turnaround is anticipated in the second half of the year, with leading companies showing resilience [13][14] - Recommendations include focusing on leading brands like Moutai for their strong market positions and potential for growth [14] Snack and Beverage Sector Trends - The snack and beverage sector is transitioning from aggressive expansion to a focus on existing market share, with a notable increase in health-oriented products [15][16] - The demand for functional and health-focused products is rising, with significant growth in low-sugar and no-sugar categories [15][16] Dairy Market Insights - The dairy market is showing signs of recovery, with expectations for a reduced contraction in 2026 compared to 2025 [18][19] - Leading dairy companies are likely to achieve positive growth in their liquid milk businesses, supported by improved supply-demand dynamics [19] Restaurant Supply Chain Performance - The restaurant supply chain is recovering steadily, with leading condiment companies like Haitian and Qianhe showing strong sales growth [20][21] - Future potential for the restaurant supply chain exists, driven by improved consumer confidence and potential downward CPI trends [20]

Summary of Key Points from Conference Call Records Industry Overview - **Industry**: Baijiu (Chinese liquor) and Beverage Industry - **Key Trends**: The Baijiu industry is expected to bottom out by 2027, with some third-party analysts predicting improvements starting in Q2 2026 due to low baselines and accelerated inventory clearance [1][3]. Core Insights and Arguments Baijiu Market Dynamics - **Market Sentiment**: The sentiment at the 2026 Sugar and Wine Fair was low, with a general sense of growth anxiety among industry players [2]. - **High-End vs. Mid-Range**: The market is characterized by a "two ends good, middle bad" pattern, where high-end brands like Moutai and Wuliangye are stabilizing, while mid-range products face significant pressure due to declining business consumption and price suppression [1][3]. - **Sales Performance**: Moutai's sales during the Spring Festival exceeded expectations, with stable batch prices above 1,500 yuan. Wuliangye reported double-digit growth in Q1, with inventory below 10% [1][5]. Investment Recommendations - **Recommended Stocks**: Companies like Zhenjiu Lidu, Yingjia Gongjiu, Moutai, Wuliangye, Nongfu Spring, and Dongpeng Beverage are prioritized for investment due to their brand strength and early inventory clearance [1][10]. Competitive Landscape - **Diverging Strategies**: Companies are adopting different strategies based on their market positions. For instance, Luzhou Laojiao is focusing on national expansion of low-alcohol products while maintaining high prices for premium products [6][7]. - **Emerging Trends**: New consumption trends include low-alcohol and flavored liquors, with brands targeting younger consumers [2][3]. Additional Important Insights Snack and Beverage Trends - **Snack Retail Growth**: The snack retail sector is expected to grow rapidly, with franchisees favoring "money-saving supermarkets" and innovative snack products like konjac and bean-based snacks gaining traction [1][11]. - **Beverage Innovations**: The beverage industry is seeing a shift towards health-oriented products, with a notable decline in previously popular categories like sugar-free tea [20][21]. Company-Specific Performance - **Nongfu Spring**: Expected to achieve a 31% profit increase in 2025, with double-digit revenue growth driven by both water and tea beverages in 2026 [1][21]. - **Dongpeng Beverage**: Anticipated to maintain high growth rates, particularly in energy drinks, with Q1 revenue and profit growth projected to be in the mid-double digits [22]. Market Challenges - **Inventory Management**: Companies like Wuliangye and Luzhou Laojiao are focusing on inventory clearance to stabilize their financials, while others like Fenjiu aim to maintain performance amidst external pressures [6][10]. Future Outlook - **Investment Strategy**: The investment strategy should focus on companies that have successfully cleared inventory and are showing signs of financial recovery, such as Zhenjiu Lidu and Yingjia Gongjiu, while keeping an eye on the performance of Luzhou Laojiao and Fenjiu for potential growth [10]. This summary encapsulates the key points from the conference call records, highlighting the current state and future outlook of the Baijiu and beverage industries, along with specific company performances and investment recommendations.

Investment Rating - The report gives a "Buy" rating for the company, marking its first coverage [10]. Core Insights - Sanyuan Foods is a leading dairy enterprise in North China, focusing on the Beijing-Tianjin-Hebei market and low-temperature products. The new management team is driving organizational streamlining and channel optimization, launching key products like "Beijing Fresh Milk" to solidify its market share in low-temperature fresh milk [3][5]. - The company is transitioning from diversified expansion to a profit-oriented structure, with projected revenue composition for 2024 being approximately 63% liquid milk, 23% ice cream, and 14% solid milk [5][21]. - The management team has undergone significant changes, with a focus on profitability and cash flow, leading to a substantial reduction in organizational size and optimization of marketing systems [32]. Summary by Sections Company Overview - Sanyuan Foods is a well-known fresh milk brand in Northern China and a significant player in the production of ice cream and other dairy products. The company has shifted from a diversified expansion strategy to focusing on liquid milk, ice cream, and selected solid milk products [5][19]. Market Dynamics - The dairy industry in China is experiencing structural growth, particularly in deep-processed and low-temperature liquid milk. The per capita consumption of dairy products in China is expected to reach approximately 40.5 kg per person per year in 2024, indicating significant room for growth compared to global averages [6][43]. - The low-temperature liquid milk segment is projected to maintain a growth rate faster than that of ambient liquid milk, with penetration rates expected to exceed 30% by 2026 [6][45]. Strategic Focus - The company is concentrating on the Beijing market and enhancing its low-temperature product offerings. Recent product launches include "Beijing Fresh Milk" and "Beijing Yogurt," aimed at consolidating market presence and supporting growth [7][41]. - The management has implemented a strategy to eliminate nearly 20% of inefficient SKUs and optimize the distribution network, reducing the number of distributors significantly [7][8]. Financial Outlook - Compared to peers, Sanyuan's profitability (net profit margin and gross profit margin) has substantial room for improvement. The focus on low-temperature products and organizational streamlining is expected to enhance profitability. Projected net profits for 2026 and 2027 are estimated at 310 million and 409 million yuan, respectively, with corresponding PE ratios of 29 and 22 times [8][41].

Core Viewpoint - The company reported a decline in revenue and net profit for 2025, with a focus on adjusting its infant formula business and expanding its lifecycle nutrition system in response to increased competition and weak demand [1][2]. Financial Performance - In 2025, the company achieved a main revenue of 18.113 billion yuan, down 12.7% year-on-year, and a net profit of 1.939 billion yuan, down 45.7% year-on-year [1]. - For the second half of 2025, the main revenue was 8.962 billion yuan, a decrease of 15.9% year-on-year, and net profit was 939 million yuan, down 44.6% year-on-year [1]. - The company proposed a final dividend of 0.129 HKD per share, along with a mid-term dividend of 0.1209 HKD, totaling a dividend payout of 2.03 billion yuan for 2025, with a dividend rate of 104.85% [1]. Market Dynamics - The infant formula sector faced weak demand and intensified competition, with newborn numbers declining to 7.92 million after a brief recovery in 2024 [1]. - The company's market share in the infant formula industry decreased to 19% in 2025 from 20.5% in 2024 [2]. Product Performance - Key products such as Xingfeifan, Zhuorui, and Zhuoyao generated revenues of 4.3 billion, 6.5 billion, and 710 million yuan respectively, with Zhuorui showing a relatively stable performance with a 3% decline [1]. - The company’s gross margin improved significantly to 68.52% in the second half of 2025, up 3.63 percentage points year-on-year, attributed to cost savings from in-house production of core raw materials [1]. Strategic Initiatives - The company is actively adjusting its infant formula offerings by launching new products and enhancing operational strategies, including a focus on international markets [2]. - Plans for 2026 include launching high-end goat milk powder and customized products, as well as expanding into North America, Mexico, and Indonesia [2]. - The company aims to develop a lifecycle nutrition system, targeting revenue of 300 million yuan from children's nutrition products and 400 million yuan from adult functional nutrition by 2026 [3]. Investment Outlook - The company is expected to see some recovery in operations in 2026, with projected revenues of 2.46 billion, 2.56 billion, and 2.65 billion yuan for 2026-2028 [3]. - The current dividend yield is 6.8%, providing a degree of certainty in returns, with a target valuation of 14 times earnings, corresponding to a target price of 4.3 HKD [3].

Investment Rating - The report maintains an "Accumulate" rating for China Feihe (6186.HK) with a current price of HKD 3.68 [1] Core Insights - In 2025, China Feihe achieved revenue of CNY 18.11 billion, a year-on-year decrease of 12.7%, and a net profit attributable to shareholders of CNY 1.94 billion, down 45.7% [4][5] - The infant formula business, which accounts for 88% of total revenue, faced pressure due to declining birth rates and increased competition, resulting in a revenue decline of 16.8% [5] - Despite challenges, the company remains a market leader with a 19% market share and high brand recognition [5] - New high-end products launched in 2025 have shown promising performance and are expected to contribute to revenue growth [5][8] - The company plans to maintain a high dividend policy, distributing no less than CNY 2 billion in dividends for 2025 [7] Financial Performance Summary - Revenue and profit forecasts for 2026-2028 have been adjusted downwards due to weak demand for infant formula, with projected net profits of CNY 2.29 billion in 2026 and CNY 2.45 billion in 2027 [8][11] - The overall gross margin for 2025 was 65.0%, a decrease of 1.3 percentage points, primarily due to an increase in low-margin raw material sales [7] - The company has a strong cash flow position, with operating cash flow projected to improve in the coming years [13] Market Expansion - In 2025, overseas revenue reached CNY 230 million, with significant growth in the Canadian market, where the company received its first foreign infant formula production license [8] - Plans for 2026 include entering the U.S. and Mexican markets, further expanding North American operations [8] Valuation and Earnings Forecast - The current stock price corresponds to a price-to-earnings ratio of 13x for 2026, 12x for 2027, and 11x for 2028, indicating a favorable valuation for a leading player in the domestic milk powder industry [8][11]

Investment Rating - The investment rating for the company is "Buy" [2] Core Insights - The company reported a revenue of 5.633 billion yuan in 2025, representing a year-on-year growth of 16.29%. The net profit attributable to shareholders was 118 million yuan, with a year-on-year increase of 4.29%. The adjusted net profit reached 158 million yuan, showing a significant year-on-year growth of 235.94% [2][4] - In Q4 2025, the company achieved a revenue of 1.676 billion yuan, which is a 34.13% increase year-on-year. However, the net profit attributable to shareholders was a loss of 57.44 million yuan, a decline of 301.01% year-on-year. The adjusted net profit for this quarter was 37.89 million yuan, reflecting a year-on-year increase of 347.78% [2][4] - The growth in cheese products significantly contributed to the revenue increase in Q4 2025, with cheese revenue reaching 1.313 billion yuan, a year-on-year growth of 38.98%. The overall revenue from cheese for the year was 4.615 billion yuan, up 22.84% year-on-year [4] Financial Performance Summary - The company’s total revenue is projected to grow from 4.844 billion yuan in 2024 to 8.750 billion yuan in 2028, with a compound annual growth rate (CAGR) of approximately 14.4% [5] - The net profit attributable to shareholders is expected to increase from 114 million yuan in 2024 to 598 million yuan in 2028, reflecting a CAGR of approximately 30.6% [5] - The gross margin is projected to improve slightly from 28.3% in 2024 to 29.5% in 2028, indicating a focus on cost efficiency [5] Earnings Forecast - The expected earnings per share (EPS) for the company are projected to be 0.62 yuan in 2026, 0.90 yuan in 2027, and 1.17 yuan in 2028, with corresponding price-to-earnings (P/E) ratios of 31X, 21X, and 16X respectively [4][5]

Investment Rating - The report maintains a "Buy" rating for China Feihe (06186.HK) with a target price of HKD 4.3 [1] Core Views - The company reported a main revenue of CNY 18.113 billion for 2025, a decrease of 12.7% year-on-year, and a net profit of CNY 1.939 billion, down 45.7% year-on-year. The second half of 2025 saw a revenue of CNY 8.962 billion, down 15.9% year-on-year, and a net profit of CNY 939 million, down 44.6% year-on-year. The company plans to distribute a final dividend of HKD 0.129 per share, along with a mid-term dividend of HKD 0.1209, totaling a dividend payout of CNY 2.03 billion, with a payout ratio of 104.85% [1][6] Financial Performance Summary - Total revenue for 2025 was CNY 18.113 billion, with a projected growth of 2.7% in 2026, 1.9% in 2027, and 1.6% in 2028 [1][12] - Net profit for 2025 was CNY 1.939 billion, with expected growth of 27.0% in 2026, 4.0% in 2027, and 3.6% in 2028 [1][12] - Earnings per share (EPS) for 2025 was CNY 0.21, projected to increase to CNY 0.27 in 2026, CNY 0.28 in 2027, and CNY 0.29 in 2028 [1][12] - The price-to-earnings (P/E) ratio is expected to be 15 for 2025, decreasing to 12 for 2026 and 2027, and 11 for 2028 [1][12] - The price-to-book (P/B) ratio is projected to be 1.2 for 2025 and 2026, decreasing to 1.1 in 2028 [1][12] Business Strategy and Market Position - The company is facing pressure in its core infant formula business due to weak demand and increased competition, with a market share of 19% in the infant formula sector, down from 20.5% in 2024 [6] - The company is actively adjusting its product offerings and operations, launching new products and enhancing user engagement across the supply chain [6] - New product launches in the infant formula segment have shown promising sales, with the new series generating CNY 69 million in sales within a month of launch [6] - The company is expanding its international presence, having entered over 1,600 mainstream channels in Canada and capturing a 2% market share [6] Emerging Business Development - The company is developing a full lifecycle nutrition system, focusing on children's and adult nutrition products, with revenue targets of CNY 300 million for children's nutrition and CNY 400 million for adult nutrition by 2026 [6] - The company has seen significant growth in its other dairy products, achieving CNY 2.06 billion in revenue for 2025, a 36.1% increase year-on-year [6]